CN103339141B - 作为hiv成熟抑制剂的c-3修饰的桦木酸衍生物的c-28胺 - Google Patents
作为hiv成熟抑制剂的c-3修饰的桦木酸衍生物的c-28胺 Download PDFInfo
- Publication number
- CN103339141B CN103339141B CN201280007020.0A CN201280007020A CN103339141B CN 103339141 B CN103339141 B CN 103339141B CN 201280007020 A CN201280007020 A CN 201280007020A CN 103339141 B CN103339141 B CN 103339141B
- Authority
- CN
- China
- Prior art keywords
- alkyl
- methyl
- octahydro
- pentamethyl
- prop
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CN(CC*)C=C*=C Chemical compound CN(CC*)C=C*=C 0.000 description 11
- QSYTWBKZNNEKPN-UHFFFAOYSA-N CC(C)(C)OC(N1CCN(CCN)CC1)=O Chemical compound CC(C)(C)OC(N1CCN(CCN)CC1)=O QSYTWBKZNNEKPN-UHFFFAOYSA-N 0.000 description 1
- ROOIZNDAYDABMA-GXYXSIBPSA-N CC(C)([C@@H]1CC2)C(c(cc3)ccc3C(O)=O)=CC[C@]1(C)[C@@H](CC1)[C@]2(C)[C@@]2(C)[C@H]1[C@@H]([C@@H](CC1)C(C)=C)[C@@]1(CNCCNC(C)=C)CC2 Chemical compound CC(C)([C@@H]1CC2)C(c(cc3)ccc3C(O)=O)=CC[C@]1(C)[C@@H](CC1)[C@]2(C)[C@@]2(C)[C@H]1[C@@H]([C@@H](CC1)C(C)=C)[C@@]1(CNCCNC(C)=C)CC2 ROOIZNDAYDABMA-GXYXSIBPSA-N 0.000 description 1
- WSAXXWRZQRYWGS-UHFFFAOYSA-N CC(CCN(CC1)CC[S]1(=O)#N)CN Chemical compound CC(CCN(CC1)CC[S]1(=O)#N)CN WSAXXWRZQRYWGS-UHFFFAOYSA-N 0.000 description 1
- LNWWQYYLZVZXKS-UHFFFAOYSA-N CC(N1CCCC1)=O Chemical compound CC(N1CCCC1)=O LNWWQYYLZVZXKS-UHFFFAOYSA-N 0.000 description 1
- HSQJBCLGDNMSNL-UHFFFAOYSA-N CC(O)S1CCN(CCCNCC(CCC2C(C)=C)(CC3)C2C(CC2)C3(C)C(C)(CC3)C2C2(C)C3C(C)(C)C(c(cc3)ccc3C(O)=O)=CC2)CC1 Chemical compound CC(O)S1CCN(CCCNCC(CCC2C(C)=C)(CC3)C2C(CC2)C3(C)C(C)(CC3)C2C2(C)C3C(C)(C)C(c(cc3)ccc3C(O)=O)=CC2)CC1 HSQJBCLGDNMSNL-UHFFFAOYSA-N 0.000 description 1
- CWLYJNKEQIWEIF-HWTGJUDZSA-N CC1(C)C(c(cc2)ccc2C(O)=O)=CC[C@](C)([C@@H](CC2)[C@@](C)(CC3)[C@@]4(C)C2(C)[C@@H]([C@@H](CC2)C(C)=C)[C@@]2(CNCCN(CCO)CCO)CC4)[C@]13N=C Chemical compound CC1(C)C(c(cc2)ccc2C(O)=O)=CC[C@](C)([C@@H](CC2)[C@@](C)(CC3)[C@@]4(C)C2(C)[C@@H]([C@@H](CC2)C(C)=C)[C@@]2(CNCCN(CCO)CCO)CC4)[C@]13N=C CWLYJNKEQIWEIF-HWTGJUDZSA-N 0.000 description 1
- LBNPEISQJLONDM-BTJQGHSGSA-N CCC(C)(CC1)[C@H]([C@H]2CC3)C1(CN(C)C)CC[C@@]2(C)[C@](C)(CC[C@H]1C(C)(C)C(C(CC2)=CC=C2C(O)=O)=CCC[C@@]11C)[C@]31N Chemical compound CCC(C)(CC1)[C@H]([C@H]2CC3)C1(CN(C)C)CC[C@@]2(C)[C@](C)(CC[C@H]1C(C)(C)C(C(CC2)=CC=C2C(O)=O)=CCC[C@@]11C)[C@]31N LBNPEISQJLONDM-BTJQGHSGSA-N 0.000 description 1
- GAKMLHBPAGIWBO-UHFFFAOYSA-N CCOC(CN)/[O]=C/C Chemical compound CCOC(CN)/[O]=C/C GAKMLHBPAGIWBO-UHFFFAOYSA-N 0.000 description 1
- QMHAHUAQAJVBIW-UHFFFAOYSA-N CN(C)S(N)(=O)=O Chemical compound CN(C)S(N)(=O)=O QMHAHUAQAJVBIW-UHFFFAOYSA-N 0.000 description 1
- SUMNGSPPKFDRTP-GXXIKKGZSA-N C[C@@H]1[C@](CC[C@](C)(CCC2)[C@](C)(CC3)C2[C@]2(C)[C@@H]3C(C)(C)C(c(cc3)cc(F)c3C(O)=O)=CC2)(CNCCCN(CCC2)C2=O)CCC1 Chemical compound C[C@@H]1[C@](CC[C@](C)(CCC2)[C@](C)(CC3)C2[C@]2(C)[C@@H]3C(C)(C)C(c(cc3)cc(F)c3C(O)=O)=CC2)(CNCCCN(CCC2)C2=O)CCC1 SUMNGSPPKFDRTP-GXXIKKGZSA-N 0.000 description 1
- DFWOXJWEBGETJF-UHFFFAOYSA-N C[I](CCCN)NC=[IH] Chemical compound C[I](CCCN)NC=[IH] DFWOXJWEBGETJF-UHFFFAOYSA-N 0.000 description 1
- WVFZXCIIJBHBAA-UHFFFAOYSA-N NCCC(N1CCOCC1)=O Chemical compound NCCC(N1CCOCC1)=O WVFZXCIIJBHBAA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161437870P | 2011-01-31 | 2011-01-31 | |
| US61/437870 | 2011-01-31 | ||
| US61/437,870 | 2011-01-31 | ||
| PCT/US2012/022847 WO2012106188A1 (en) | 2011-01-31 | 2012-01-27 | C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103339141A CN103339141A (zh) | 2013-10-02 |
| CN103339141B true CN103339141B (zh) | 2016-08-24 |
Family
ID=45567146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280007020.0A Expired - Fee Related CN103339141B (zh) | 2011-01-31 | 2012-01-27 | 作为hiv成熟抑制剂的c-3修饰的桦木酸衍生物的c-28胺 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8748415B2 (https=) |
| EP (1) | EP2670764B1 (https=) |
| JP (1) | JP6000283B2 (https=) |
| CN (1) | CN103339141B (https=) |
| BR (1) | BR112014010105A2 (https=) |
| CA (1) | CA2826257A1 (https=) |
| CY (1) | CY1116989T1 (https=) |
| DK (1) | DK2670764T3 (https=) |
| EA (1) | EA023578B1 (https=) |
| ES (1) | ES2552512T3 (https=) |
| HR (1) | HRP20151212T1 (https=) |
| HU (1) | HUE026371T2 (https=) |
| MX (1) | MX2013008359A (https=) |
| PL (1) | PL2670764T3 (https=) |
| PT (1) | PT2670764E (https=) |
| RS (1) | RS54352B1 (https=) |
| SI (1) | SI2670764T1 (https=) |
| SM (1) | SMT201500303B (https=) |
| WO (1) | WO2012106188A1 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013043778A1 (en) | 2011-09-21 | 2013-03-28 | Bristol-Myers Squibb Company | Novel betulinic acid derivatives with antiviral activity |
| US8906889B2 (en) | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
| RU2519133C1 (ru) * | 2012-11-09 | 2014-06-10 | Леонид Леонидович Клопотенко | Мазь, содержащая инкапсулированную тритерпеновую кислоту или ее производные |
| RU2516952C1 (ru) * | 2012-11-09 | 2014-05-20 | Леонид Леонидович Клопотенко | Фармацевтическая композиция, содержащая инкапсулированную тритерпеновую кислоту или ее производные |
| CN103214543B (zh) * | 2012-12-25 | 2015-09-02 | 中国人民解放军海军医学研究所 | 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用 |
| SG11201505639SA (en) | 2013-02-06 | 2015-08-28 | Bristol Myers Squibb Co | C-19 modified triterpenoids with hiv maturation inhibitory activity |
| SG11201506445PA (en) * | 2013-02-25 | 2015-09-29 | Bristol Myers Squibb Co | C-3 alkyl and alkenyl modified betulinic acid derivatives useful in the treatment of hiv |
| SI3129392T1 (sl) | 2014-04-11 | 2020-11-30 | VIIV Healthcare UK(No.4) Limited | Triterpenoidi z inhibitorno aktivnostjo maturacije HIV-a, substituirani na položaju 3 z nearomatskim obročem, ki nosi haloalkilni substituent |
| WO2015195776A1 (en) * | 2014-06-19 | 2015-12-23 | Bristol-Myers Squibb Company | Betulinic acid derivatives with hiv maturation inhibitory activity |
| CN107250153A (zh) * | 2014-11-14 | 2017-10-13 | Viiv保健英国第五有限公司 | 氧代羽扇豆烯衍生物 |
| EP3218388A1 (en) | 2014-11-14 | 2017-09-20 | VIIV Healthcare UK (No.5) Limited | C17-aryl substituted betulinic acid analogs |
| KR20170092580A (ko) * | 2014-11-14 | 2017-08-11 | 비브 헬스케어 유케이 (넘버5) 리미티드 | 연장된 베툴린산 유사체 |
| RU2017134461A (ru) * | 2015-04-14 | 2019-05-14 | ВАЙВ ХЕЛТКЕР ЮКей (N4) ЛИМИТЕД | Способы получения ингибитора созревания HIV |
| WO2017017609A1 (en) | 2015-07-28 | 2017-02-02 | Glaxosmithkline Intellectual Property (No.2) Limited | Betuin derivatives for preventing or treating hiv infections |
| RU2018105352A (ru) | 2015-07-28 | 2019-08-29 | ГлаксоСмитКлайн Интеллекчуал Проперти (N2) Лимитед | Производные бетулина для предупреждения или лечения ВИЧ-инфекций |
| RU2018112958A (ru) | 2015-09-24 | 2019-10-28 | ГлаксоСмитКлайн Интеллекчуал Проперти (N2) Лимитед | Соединения с ингибирующей созревание ВИЧ активностью |
| WO2017125870A1 (en) | 2016-01-20 | 2017-07-27 | Glaxosmithkline Intellectual Property (No.2) Limited | Amine derivatives of lupanes with hiv maturation inhibitory activity |
| AR107512A1 (es) | 2016-02-04 | 2018-05-09 | VIIV HEALTHCARE UK Nº 5 LTD | Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1 |
| US20190135857A1 (en) * | 2016-06-30 | 2019-05-09 | Viiv Healthcare Uk (No. 5) Limited | Triterpenoid inhibitors of human immunodeficiency virus replication |
| WO2019055280A1 (en) | 2017-09-13 | 2019-03-21 | Emmyon, Inc. | DIETHANOLAMINE SALTS AND URSOLIC ACID MORPHOLIN |
| RU2020113341A (ru) | 2017-09-14 | 2021-10-15 | Феникс Байотекнолоджи, Инк. | Способ и композиция для лечения вирусной инфекции |
| KR20200083969A (ko) | 2017-09-14 | 2020-07-09 | 피닉스 바이오테크놀러지 인코포레이티드. | 신경학적 상태를 치료하기 위한 방법 및 개선된 신경보호 조성물 |
| ES2970042T3 (es) | 2018-04-24 | 2024-05-24 | Viiv Healthcare Uk No 5 Ltd | Compuestos con actividad inhibidora de la maduración del VIH |
| PL237998B1 (pl) | 2018-05-28 | 2021-06-28 | Narodowy Inst Lekow | Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie |
| US10343997B1 (en) | 2018-12-04 | 2019-07-09 | King Saud University | Ursolic acid derivatives |
| EP4009981B1 (en) | 2020-03-31 | 2023-08-16 | Phoenix Biotechnology, Inc. | Method and compositions for treating coronavirus infection |
| JP7153083B2 (ja) | 2020-03-31 | 2022-10-13 | フェニックス・バイオテクノロジー・インコーポレイテッド | コロナウイルス感染を治療するための方法および組成物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101142227A (zh) * | 2004-11-12 | 2008-03-12 | 帕纳克斯医药公司 | 新颖的桦木醇衍生物、其制备和其用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| US5962527A (en) | 1995-03-21 | 1999-10-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating cancers |
| US5869535A (en) | 1995-03-21 | 1999-02-09 | The Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma |
| US5679828A (en) | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US7365221B2 (en) | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| US20050014730A1 (en) | 2003-04-02 | 2005-01-20 | Carlson Robert M. | Anti-fungal formulation of triterpene and essential oil |
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| EP1730163A4 (en) | 2004-03-17 | 2009-12-30 | Panacos Pharmaceuticals Inc | Pharmaceutical salts of 3-O- (3,3-dimethylsuccinyl) betulinic acid |
| TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| WO2008127364A2 (en) | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
| WO2008115281A2 (en) | 2006-10-16 | 2008-09-25 | Myriad Genetics, Inc. | Compounds for treating viral infections |
| CA2714049A1 (en) * | 2008-02-14 | 2009-08-20 | Virochem Pharma Inc. | Novel 17.beta. lupane derivatives |
| US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| US8802661B2 (en) * | 2010-06-04 | 2014-08-12 | Bristol-Myers Squibb Company | C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors |
| CN103038245B (zh) * | 2010-06-04 | 2015-03-25 | 百时美施贵宝公司 | 作为hiv成熟抑制剂的c-3经修饰的桦木酸衍生物 |
| KR101886467B1 (ko) * | 2011-01-31 | 2018-08-07 | 비브 헬스케어 유케이 (넘버4) 리미티드 | Hiv 성숙 억제 활성을 갖는 c-17 및 c-3 변형 트리테르페노이드 |
-
2012
- 2012-01-27 PL PL12702946T patent/PL2670764T3/pl unknown
- 2012-01-27 BR BR112014010105A patent/BR112014010105A2/pt unknown
- 2012-01-27 CA CA2826257A patent/CA2826257A1/en not_active Abandoned
- 2012-01-27 US US13/359,680 patent/US8748415B2/en not_active Expired - Fee Related
- 2012-01-27 JP JP2013551360A patent/JP6000283B2/ja not_active Expired - Fee Related
- 2012-01-27 EP EP12702946.0A patent/EP2670764B1/en active Active
- 2012-01-27 ES ES12702946.0T patent/ES2552512T3/es active Active
- 2012-01-27 CN CN201280007020.0A patent/CN103339141B/zh not_active Expired - Fee Related
- 2012-01-27 EA EA201391098A patent/EA023578B1/ru not_active IP Right Cessation
- 2012-01-27 SI SI201230354T patent/SI2670764T1/sl unknown
- 2012-01-27 WO PCT/US2012/022847 patent/WO2012106188A1/en not_active Ceased
- 2012-01-27 DK DK12702946.0T patent/DK2670764T3/en active
- 2012-01-27 HR HRP20151212TT patent/HRP20151212T1/hr unknown
- 2012-01-27 HU HUE12702946A patent/HUE026371T2/en unknown
- 2012-01-27 RS RS20150740A patent/RS54352B1/sr unknown
- 2012-01-27 MX MX2013008359A patent/MX2013008359A/es active IP Right Grant
- 2012-01-27 PT PT127029460T patent/PT2670764E/pt unknown
-
2015
- 2015-12-01 CY CY20151101099T patent/CY1116989T1/el unknown
- 2015-12-01 SM SM201500303T patent/SMT201500303B/it unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101142227A (zh) * | 2004-11-12 | 2008-03-12 | 帕纳克斯医药公司 | 新颖的桦木醇衍生物、其制备和其用途 |
Non-Patent Citations (1)
| Title |
|---|
| Synthesis and Anti-HIV Activity of Oleanolic Acid Derivatives;Yong-Ming Zhu,等;《Bioorganic & Medicinal Chemistry Letters》;20011231;第11卷;3115-3118 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2013008359A (es) | 2013-08-27 |
| US8748415B2 (en) | 2014-06-10 |
| CA2826257A1 (en) | 2012-08-09 |
| EA023578B1 (ru) | 2016-06-30 |
| CN103339141A (zh) | 2013-10-02 |
| SI2670764T1 (sl) | 2016-03-31 |
| JP2014507422A (ja) | 2014-03-27 |
| JP6000283B2 (ja) | 2016-09-28 |
| DK2670764T3 (en) | 2015-12-07 |
| BR112014010105A2 (pt) | 2017-06-13 |
| PL2670764T3 (pl) | 2016-02-29 |
| EP2670764B1 (en) | 2015-09-02 |
| CY1116989T1 (el) | 2017-04-05 |
| HRP20151212T1 (hr) | 2015-12-04 |
| PT2670764E (pt) | 2015-11-20 |
| RS54352B1 (sr) | 2016-02-29 |
| EP2670764A1 (en) | 2013-12-11 |
| ES2552512T3 (es) | 2015-11-30 |
| SMT201500303B (it) | 2016-01-08 |
| HUE026371T2 (en) | 2016-05-30 |
| US20130029954A1 (en) | 2013-01-31 |
| WO2012106188A1 (en) | 2012-08-09 |
| EA201391098A1 (ru) | 2013-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103339141B (zh) | 作为hiv成熟抑制剂的c-3修饰的桦木酸衍生物的c-28胺 | |
| CN102985438B (zh) | 作为hiv成熟抑制剂的经修饰c-3桦木酸衍生物的c-28酰胺 | |
| CN103429607B (zh) | 具有hiv成熟抑制活性的c-17和c-3经修饰的三萜系化合物 | |
| TWI574973B (zh) | 具有ｈｉｖ成熟抑制活性之ｃ－１７雙環胺三萜類化合物 | |
| CN103038245B (zh) | 作为hiv成熟抑制剂的c-3经修饰的桦木酸衍生物 | |
| TWI659964B (zh) | 具有ｈｉｖ成熟抑制活性之三萜化合物 | |
| TW201444862A (zh) | Ｃ－３烷基及烯基經修飾樺木酸衍生物 | |
| CN104220451A (zh) | 具有hiv成熟抑制活性的c-3环烯三萜类化合物 | |
| RS64915B1 (sr) | Novi derivati triterpena kao inhibitori hiv-a | |
| HK40041853A (en) | Triterpenoids with hiv maturation inhibitory activity | |
| EA045041B1 (ru) | Новые тритерпеновые производные в качестве ингибиторов вич | |
| HK1232548B (en) | Triterpenoids with hiv maturation inhibitory activity, substituted in position 3 by a non-aromatic ring carrying a haloalkyl substituent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20190127 |